Need for More Research While current studies are promising, researchers agree that more research is needed
Healthcare providers report increased pressure from patients who view GLP-1s as a quick fix rather than part of a comprehensive health strategy
Limited Human Clinical Data The most significant limitation is the scarcity of rigorous, peer-reviewed human clinical trials: Few independent clinical trials published in peer-reviewed scientific journals Most efficacy data derived from manufacturer-sponsored studies or in silico modeling No large-scale, multi-center clinical trials examining long-term outcomes Limited data on optimal concentration, application frequency, and treatment duration Demographic diversity of studied populations not well-characterized The primary human efficacy data comes from a 50-subject study and various smaller manufacturer trials, representing a narrow evidence base for such a widely used cosmetic ingredient
Vaduganathan M, Docherty KF, Claggett BL, Jhund PS, de Boer RA, Hernandez AF, et al
Is PDA the same as BPC-157
It's involved in over 300 enzyme reactions in your body, helping your muscles contract properly and supporting energy production
